Publications

Evidence of our team's scientific rigour and commitment to medical advancement can be found in our extensive library of Niche Publications. We believe that sharing the results of our collaborative research is essential for fostering innovation and improving patient outcomes.

This resource brings together our peer reviewed papers, conference presentations, and technical posters, showcasing our deep expertise across a broad range of therapeutic areas from cardiovascular endocrinology to complex frailty studies. By making our published work accessible, we aim to contribute to the global scientific dialogue and provide our partners with a transparent look at the high standard clinical and analytical thinking that underpins every Niche project.

Explore our bibliography to see how we are helping to shape the future of medicine.

Acknowledged Publications

Recognised contributions to world-class research

A selection of peer-reviewed publications where Niche's scientific and clinical expertise has been formally acknowledged by research teams worldwide, reflecting the breadth and depth of our contribution to advancing medical knowledge.

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria

Written by

Ariceta G, Collard L, Abroug S, Moochhala SH, Gould E, Boussetta A, Ben Hmida M, De S, Hunley TE, Jarraya F, Fraga G, Banos A, Lindner E, Dehmel B, Schalk G.

Explore The Publication

Azoximer Bromide: Mystery, Serendipity, and Promise

Written by

Grivtsova LY, Falaleeva NA, Tupitsyn NN.

Explore The Publication

« Previous 1 2 3 4 5 6 … 58 Next »

Niche Manuscripts

Where our words shape the science

Publications where the Niche medical writing team played a central role in crafting the manuscript itself — translating complex clinical data into clear, compelling and submission-ready scientific communications.

Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation

Written by

Diver S, Haldar K, McDowell PJ, Busby J, Mistry V, Micieli C, Brown V, Cox C, Yang F, Borg C, Shrimanker R, Ramsheh MY, Hardman T, Arron J, Bradding P, Cowan D, Mansur AH, Fowler SJ, Lordan J, Menzies-Gow A, Robinson D, Matthews J, Pavord ID, Chaudhuri R, Heaney LG, Barer MR, Brightling C; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium).

Explore The Publication

Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes

Written by

McDowell PJ, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker S, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan D, Mansur AH, Fowler SJ, Diver SE, Howarth P, Lordan J, Menzies-Gow A, Harrison T, Robinson DS, Holweg CTJ, Matthews JG, Pavord ID, Heaney LG.

Explore The Publication

« Previous 1 2 3 4 5 6 … 47 Next »

Publications

Acknowledged Publications

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria

Azoximer Bromide: Mystery, Serendipity, and Promise

Niche Manuscripts

Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation

Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes

Hi ✋